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ABSTRACT 
 
BACKGROUND: Symptoms of malaria and pneumonia overlap in African under-five children and the integrated 
management  of  childhood  illness  strategy  require  that  such  children  be  managed  presumptively  with  both 
antibiotics  and  antimalarials.  A  2003  WHO  expert  meeting  recommended  the  evaluation  of  malaria  rapid 
diagnostic test in the management of children with this overlap, but this has not been evaluated. Therefore, the 
objective of this study was to compare the clinical outcome of presumptive versus malaria rapid diagnostic test -
based management of childhood malaria-pneumonia overlap in Nigeria. 
METHODS: A pilot quasi-experimental study was conducted November 2009 through February 2010 in an urban 
comprehensive health centre in Ogun, South-Western Nigeria. First, 50 children with malaria-pneumonia symptom 
overlap  were  consecutively  enrolled and  treated presumptively with  antibiotics and  antimalarials  irrespective of 
malaria  test  result  (control arm).Then,  another  50  eligible  children  were  enrolled  and  treated  with  antibiotics 
with/out antimalarials based on rapid diagnostic test result (intervention arm). Primary endpoint: clinical cure at 
day-5. The data were analyzed using Epi Info version 3.4.1.  
RESULTS:  The  intervention  and  control  arms  did  not  differ  significantly  regarding  patient  demographic  and 
clinical characteristics. Clinical cure rate was slightly higher in children managed presumptively 49 (98%) than 
those  managed  rapid  diagnostic  test  -based 47  (94%)  (P  =  0.31).  However,  rapid diagnostic test  -based  treated 
children had lower risk of receiving antimalarials compared to those treated presumptively (48% vs. 100%), (P = 
<0.001; relative risk 2.08, CI 1.56 to 2.78). No death or severe complications were recorded in either group at day-5 
follow-up. 
CONCLUSION:  Outcome of rapid diagnostic test-based treatment is not inferior to presumptive management in 
children with malaria-pneumonia symptom overlap. More extensive studies with larger sample sizes are needed.  
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INTRODUCTION 
 
Because of the symptom overlap between malaria and 
pneumonia  in  African  children,  the  World  Health 
Organization  (WHO)  Integrated  Management  of 
Childhood  Illness  (IMCI)  strategy  requires  that such 
children  be  managed  presumptively  with  both 
antibiotics  and  antimalarials  (1,  2).  The  widespread 
adoption  of  artemisinin  based  combination  therapy 
antimalarials  in  low-resource  settings  and  the 
availability  of  malaria  rapid  diagnostic  tests  (RDTs) 
have led to the modification of the malaria treatment 
policy  by  the  WHO.  The  policy  recommended 
malarial  treatment  only  after  parasitological 
confirmation-this  recommendation  had  initially  been 
restricted  to  older  children  and  adults,  but  in  the 
guideline’s second edition (released 2
nd March 2010) 
the RDT-based policy has been extended to younger 
children (3). 
Although  the  accuracy  of  RDTs  for  malaria 
infection  has been  demonstrated  (4),  there  is  limited 
evidence  for  the safety of  a  test –based strategy  for 
children  below  five  years  (5,  6).  Also,  though  the 
safety of not treating RDT negative children has been 
confirmed, such studies were conducted mainly in the 
context  of  childhood  fevers  (7).  In  2003,  a  WHO 
consultative  meeting  on  childhood  pneumonia 
recommended that studies to improve the specificity of 
clinical overlap for  malaria and pneumonia diagnosis 
should  be  undertaken,  and  rapid  diagnostic  tests  for 
malaria should be studied to differentiate malaria from  
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pneumonia (8). We found no study that evaluated the 
use  of  RDT  in  the  treatment  of  childhood  malaria  – 
pneumonia  overlap.  Therefore,  this  study  was 
conducted  to  compare  the outcome  of  presumptively 
treated  children  having  this  overlap  with  antibiotics 
and  antimalarials  irrespective  of  malaria  test  result 
versus  children  treated  with  antibiotics  with/out 
antimalarials based on RDT result in an area of high 
malaria transmission. 
 
PATIENTS AND METHODS 
 
This  was  a  pilot  quasi-experimental  study conducted 
November  2009  through  February  2010.  First, 
November through December 2009, fifty children with 
malaria-pneumonia  symptom  overlap  were 
consecutively enrolled and treated presumptively with 
antibiotics  and  antimalarials  irrespective  of  malaria 
test  results  according  to  national/  WHO/UNICEF 
guidelines  (control  arm).  Then,  January  through 
February  2010,  another  50  eligible  children  were 
consecutively  enrolled  and  treated  with  antibiotics 
with/out  antimalarials  based  on  rapid  diagnostic  test 
result  (intervention  arm).  The  primary  endpoint  was 
clinical  cure  at  day-5.  Secondary  endpoints  were 
frequency  of  clinic  re-attendance;  persistence  of 
presenting problems  at  follow-up,  and  proportion  of 
unnecessary antimalarial treatment.  
The study was performed in an urban comprehensive 
health  centre  in  Abeokuta-south district,  Ogun  state, 
South-western Nigeria. The health centre is located in 
the rain forest belt of Nigeria, an area  with perennial 
malaria transmission.  
Inclusion  criteria  were;  age  2  –  59months,  clinical 
(IMCI)  malaria  (defined  as  axillary  temperature  of 
≥37.5°C  or  a  history  of  fever  within  48hours  of 
presentation) with clinical (IMCI) pneumonia (defined 
as a presence/history of cough and difficult breathing 
along with clinician counting of respiratory rate above 
IMCI cut-offs – a  rate of  40 per-minute for children 
aged  12-59months  and  above  50  per-minute  for 
children 2-12months), living within 3 kilometers of the 
health  centre,  and  provision  of  informed  consent. 
Exclusion criteria were; severe clinical state requiring 
urgent attention; presence of co-morbidities like otitis 
media, persistent vomiting, diarrhea etc. 
The children were examined by a study clinician and 
their  axillary  temperature  was  measured.  Capillary 
blood was obtained and malaria rapid diagnostic test 
was  performed  by  a  laboratory  technician  using 
Paracheck  Pf  (Orchid  Biomedical Systems,  India).In 
the  control  arm,  all  the  study  children  received  oral 
antimalarial  (artesunate  –  amodiaquine  combination 
antimalarials) and antibiotic (amoxicillin)  irrespective 
of RDT  result. And in the intervention arm, children 
with a positive RDT result received both antimalarial 
and antibiotics while those with a negative RDT result 
received antibiotic only. The artesunate – amodiaquine 
combination  antimalarials  used  was  a  3-day  regimen 
pre-packaged  for  children  2-11  months  or  12-59 
months.  The  oral  amoxicillin  (antibiotics)  used  was 
prescribed  at  50mg/kg/day  in  two  divided  doses  for 
five days.   
All data were recorded in a standard IMCI forms and a 
follow-up  was  performed  for  all  patients  at  day  5. 
Patients were instructed to return for assessment at any 
time  if the symptoms deteriorated during or after the 
day-5 follow-up period. Patients who failed to visit the 
hospital were actively followed – up on day – 6.  
Data were double-entered and analyzed with Epi Info 
(CDC  Atlanta,  version  3.4.1).  Continuous  variables 
were  expressed  as  median  (±standard  deviation)  and 
categorical  variables  summarized  using  percentiles. 
Group  comparisons  were  made  (where  appropriate) 
using the  Wilcoxon  two-sample  test and  uncorrected 
chi-square test, and their corresponding P-values were 
used for statistical inference.     
Before  data  collection,  the  Research  Committee  – 
Primary Health Care and Disease Control department 
of Abeokuta-south local government area, Ogun state, 
Nigeria read and approved the study protocol.  Verbal 
informed  consent  was  obtained  from  parents/legal 
guardian of enrolled children.  
 
 
RESULTS  
 
The children in the control and intervention arms did 
not  differ  significantly  in  their  demographic  and 
clinical  characteristics  (Table  1).  Overall,  only  46% 
(95%  confidence  interval  (CI);  36%  –  56  %)  of  the 
study children had a positive malaria test using RDT. 
A cure rate of  98%  was recorded in the control arm 
versus 94% in the intervention arm (P=0.31) (Table 2). 
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Table 1: Comparison of two treatment groups at enrollment in Abeokuta-south district, Ogun Nov. 2009 – Feb. 2010. 
 
Variable  Control arm  Intervention arm  *Wilcoxon/  P – value  
  (Presumptive)  (RDT-based)  Chi-square   
Total enrolled   50  50     
Age (months)         
         ≤ 12  33 (66%)  31 (62%)  0.17  0.68 
         > 12  17 (34%)  19 (38%)     
         Median (± SD)  12 (± 11.2)  12 (± 9.4)  *1.6  0.2 
Gender         
        Male      27 (54%)  25 (50%)  0.16  0.69 
        Female  23 (46%)  25 (50%)     
Axillary temperature         
         Range  36.5 – 39.2   36.7 – 39.8     
         Median (± SD)  37.9 (± 0.79)  38 (± 0.6)  *0.8  0.77 
Malaria rapid diagnostic test         
         Positive  22 (44%)  24 (48%)  0.16  0.69 
         Negative  28 (56%)  26 (52%)     
               P-value ≤0.05 is significant, SD = Standard deviation, *Wilcoxon = based on Wilcoxon two sample test; 
             
No  death  or  severe  complications  were  recorded  in 
either  group  at  day-5  follow-up.  Median  fever 
clearance time was lower in the control arm (2± 0.65 
days) than in the intervention arm (3± 0.7 days) (P = 
<0.001). However, rapid diagnostic test -based treated 
children  had  lower  risk  of  receiving  antimalarials 
compared  to  those  treated  presumptively  (48%  vs. 
100%),  (P  =  <0.001;  relative  risk  2.08,  CI  1.56  to 
2.78).  Three  children  in  the  intervention arm  versus 
one  child  in  the  control  arm  had  persistence  of 
symptoms during follow-up (P = 0.31). A repeat RDT 
for all of them was negative and they were all referred 
to a tertiary hospital (Table 2). 
 
Table 2: Clinical outcome at follow-up (day – 5) in the two groups in Abeokuta-South district, Ogun, Nov. 2009 – Feb. 
2010. 
 
Variable  Control arm  Intervention arm  *Wilcoxon/  P – value  
  (Presumptive)  (RDT-based)   Chi-square   
Clinical cure   49/50 (98%)  47/50 (94%)   1.04  0.31 
Early clinic re-attendance  3/50 (6%)  9/50 (18%)   3.4  0.065 
Fever clearance time (days)         
           Range      2 – 4   2 – 5      
           Median (± SD)  2 (± 0.65)  3 (± 0.7)  *32.1  <0.001 
Proportion given antimalarial  50/50 (100%)  24/50 (48%)   35.1  <0.001 
Persistence of symptoms  1/50 (2%)  3/50 (6%)   1.04  0.31 
                 P-value ≤0.05 is significant, SD = Standard deviation, *Wilcoxon = based on Wilcoxon two sample test; 
 
DISCUSSION 
 
This study showed that more than half of under-five 
children  with  malaria  –  pneumonia  overlap  do  not 
have  malaria  parasitaemia  using  RDT.  Thus,  more 
than half of all antimalarials prescribed presumptively 
to  children  with  overlap  were  unnecessary.  This 
finding agrees with that of a Tanzanian study which 
showed that 43% of the fever in children was caused 
by acute respiratory infection (ARI) (9). However, it is 
not consistent with a recent Cameroonian study which 
showed  that  ARI  accounted  for  25.5%  of  fevers  in 
children  0  –  2  years  old  (10).  These  observations 
suggest  that  presumptive  management  of  malaria  – 
pneumonia  overlap  in  children  is  associated  with 
antimalarial drug wastage. Also, it risks the children to 
be exposed to unnecessary adverse drug reactions like; 
gastro-intestinal  disturbances,  neutropenia, 
hepatotoxicity  and  neurotoxicity  which  may  be 
associated with artemisinin – based therapies (11).            Ethiop J Health Sci.                               Vol.20, No. 3                       November 2010 
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After decades of presumptive treatment strategies, the 
restriction  of  antimalarials  to  parasitologically-
confirmed cases is necessarily difficult (12). Although 
recent studies have demonstrated the safety of a RDT–
based strategy for children below five years (5, 6, 10, 
12),  such  studies  were  conducted  in  the  context  of 
fevers  in  children.  We  demonstrate  that  the  clinical 
cure rate of children with malaria – pneumonia overlap 
treated based on RDT  results is not inferior to those 
managed  presumptively.  Thus,  RDT-based  strategy 
may be considered safe in the management of children 
with malaria – pneumonia overlap.  
A major drawback of the RDT – based strategy in the 
management  of  fevers  in  low  resource  settings  is 
healthcare  providers’  failure  to  adhere  to  not 
prescribing  antimalarials  to  children  with  a  negative 
test (6, 10, 12). This  may be experienced more so in 
children  who  had  malaria  –  pneumonia  overlap 
because such children will be brought to the hospital 
in  a  clinical  state  enough  to  cause  anxiety  amongst 
their  caretakers  for  they  might  have attempted home 
management  of  the  fever  as  malaria.  Although 
adopting  RDT  with  targeted  training  of  health 
professionals cannot be assumed to translate adherence 
to  treatment  based  on  test  results,  strenuous  efforts 
will  be  needed  to  understand,  and  change,  existing 
clinical behavior  where healthcare professionals have 
been used to ignoring negative malaria tests (12). 
Children managed based on RDT had a higher median 
fever  clearance  time,  and  re-attended  clinic  more 
during  follow-up  compared  to  those  managed 
presumptively. This is not consistent with observations 
of the RDT strategy made in the context of fevers in 
children (6, 10). The reason/s why a higher proportion 
of RDT-based managed children had a higher median 
fever  clearance  time  compared  to  those  managed 
presumptively  are  not  clear.  The  implication  of  late 
fever  clearance  in  patient  treated  RDT-based  is  that 
caretakers of such children are more likely to re-attend 
the  clinic  early  and  healthcare  workers  may  be 
tempted  to prescribe  antimalarials  despite  a  negative 
RDT result. 
This is a pilot study; therefore, the findings are at best 
preliminary  and  need  to  be  interpreted  with  caution. 
The study suffers from small sample size and lack of 
randomization,  and  there  may  be  error  from 
confounding  factors  from  care  seeking  practices, 
patient’s  socio-economic  status  and/or 
selection/observer  bias.    With  these  limitations,  the 
findings support the rationale for the use of RDTs in 
the  management  of  children  with  malaria-pneumonia 
overlap.  A  randomized  controlled  trial  that  has 
accommodated these limitations is required to confirm 
these findings. 
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